{"log_id": 5132062277922810184, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 0.030655, "average": 0.904857, "min": 0.384403}, "location": {"width": 464, "top": 301, "height": 61, "left": 384}, "words": "温条件下(2hC)贮时不超过小时"}, {"probability": {"variance": 0.012344, "average": 0.951976, "min": 0.406989}, "location": {"width": 802, "top": 372, "height": 80, "left": 432}, "words": "不要冰盐酸伊立替康或其溶液混合物,因为这可能导致药物沉淀形成"}, {"probability": {"variance": 0.011975, "average": 0.962983, "min": 0.552579}, "location": {"width": 450, "top": 496, "height": 59, "left": 388}, "words": "不良反应】以下来白国外临床究资料"}, {"probability": {"variance": 0.023992, "average": 0.847619, "min": 0.651468}, "location": {"width": 102, "top": 557, "height": 32, "left": 420}, "words": "联合治疗"}, {"probability": {"variance": 0.028508, "average": 0.862589, "min": 0.393576}, "location": {"width": 969, "top": 621, "height": 89, "left": 413}, "words": "在两项Ⅲ期研究中,共有995名转移性结直版患者接受盐酸立替康5-FJ/LV、单"}, {"probability": {"variance": 0.02254, "average": 0.866138, "min": 0.497544}, "location": {"width": 1021, "top": 685, "height": 93, "left": 356}, "words": "尼-FU/LV、盐波立替糜单药治疗参见8,临床研究),在这些研究中,370例思者"}, {"probability": {"variance": 0.040614, "average": 0.826322, "min": 0.403756}, "location": {"width": 1028, "top": 754, "height": 91, "left": 349}, "words": "接受了盐伊立康5./LV联合治疗,62接受了单月5-/LV治疗,23创接受了盐"}, {"probability": {"variance": 0.061472, "average": 0.790665, "min": 0.394412}, "location": {"width": 237, "top": 823, "height": 45, "left": 345}, "words": "酸立誉康单药疗"}, {"probability": {"variance": 0.034702, "average": 0.862111, "min": 0.389108}, "location": {"width": 967, "top": 893, "height": 89, "left": 393}, "words": "59名忠者(%)在最后一次治疗后30天内死亡:其中27〔7.3%>患接受盐酸"}, {"probability": {"variance": 0.019899, "average": 0.871072, "min": 0.510171}, "location": {"width": 1019, "top": 957, "height": 93, "left": 338}, "words": "伊立替/5-FULY联合治疗,13例5.3%)接受单用5-FV治疗,13例(5.8%接受盐酸伊"}, {"probability": {"variance": 0.029367, "average": 0.895712, "min": 0.377894}, "location": {"width": 1019, "top": 1024, "height": 98, "left": 329}, "words": "立康药治疗:盐酸供立替康5FLV联合治疗的者中有3例07%死亡门3例死于"}, {"probability": {"variance": 0.021337, "average": 0.894384, "min": 0.3956}, "location": {"width": 1019, "top": 1092, "height": 96, "left": 326}, "words": "中性粒细胞减少性发热/败血症),接受5ULV治疗的患考中3例(07)死亡例死于"}, {"probability": {"variance": 0.028484, "average": 0.898815, "min": 0.403312}, "location": {"width": 1021, "top": 1161, "height": 96, "left": 320}, "words": "中性粒细胞减少性发热/血症:1死于血小板减少时发生中枢神经系统出症例死因不"}, {"probability": {"variance": 0.022582, "average": 0.904027, "min": 0.448895}, "location": {"width": 1024, "top": 1227, "height": 93, "left": 317}, "words": "明),接受盐酸伊立替康草药治疗的患者中有2例(0.9%)死亡(2例死于中性粒编胞减少性"}, {"probability": {"variance": 0.023742, "average": 0.895087, "min": 0.418247}, "location": {"width": 1024, "top": 1296, "height": 96, "left": 310}, "words": "发热)与治疗有在的关联,18例(4.9)接受盐酸立替康5-FUTV联合治疗的患者,18"}, {"probability": {"variance": 0.038146, "average": 0.750543, "min": 0.419838}, "location": {"width": 1090, "top": 1353, "height": 123, "left": 304}, "words": "(0资5FUAV治疗的誉者和15例G3%受盐酸快立康单药治疗的先者在治"}, {"probability": {"variance": 0.028452, "average": 0.820435, "min": 0.441563}, "location": {"width": 1069, "top": 1428, "height": 100, "left": 299}, "words": "后6天内死亡,26测0%接登盐酸立整康P5UV联合治疗的患者,例41%接"}, {"probability": {"variance": 0.024311, "average": 0.889578, "min": 0.398643}, "location": {"width": 1088, "top": 1499, "height": 93, "left": 297}, "words": "受单用5ILV治疗的患者和26例117%接受盐酸伊立替康草药治疗的考因不良事件1"}, {"probability": {"variance": 0.000312, "average": 0.987236, "min": 0.96227}, "location": {"width": 80, "top": 1570, "height": 34, "left": 294}, "words": "而停药"}, {"probability": {"variance": 0.012195, "average": 0.941059, "min": 0.380635}, "location": {"width": 976, "top": 1627, "height": 91, "left": 336}, "words": "表5列了2项评估联合治疗的临床究中报道的3级和4级临床相关不良事件"}, {"probability": {"variance": 0.017445, "average": 0.924609, "min": 0.358083}, "location": {"width": 937, "top": 1717, "height": 89, "left": 278}, "words": "表5:在联合治疗的期临床究中发生3和4级临床相关不良事件的患者百分比"}, {"probability": {"variance": 0.020415, "average": 0.911058, "min": 0.663787}, "location": {"width": 105, "top": 1776, "height": 32, "left": 397}, "words": "不良事件"}, {"probability": {"variance": 2e-06, "average": 0.98986, "min": 0.988633}, "location": {"width": 52, "top": 1801, "height": 29, "left": 836}, "words": "试验"}, {"probability": {"variance": 0.000162, "average": 0.980774, "min": 0.968043}, "location": {"width": 77, "top": 1822, "height": 32, "left": 1241}, "words": "试验"}, {"probability": {"variance": 0.033363, "average": 0.793419, "min": 0.498373}, "location": {"width": 752, "top": 1835, "height": 77, "left": 640}, "words": "盐酸伊立替康-PU/LV酸立替康盐酸伊立登5-EU/L"}, {"probability": {"variance": 0.038388, "average": 0.787814, "min": 0.527398}, "location": {"width": 75, "top": 1888, "height": 25, "left": 658}, "words": " FU/Y"}, {"probability": {"variance": 0.032636, "average": 0.85673, "min": 0.486907}, "location": {"width": 77, "top": 1904, "height": 27, "left": 948}, "words": "N=2238"}, {"probability": {"variance": 0.079761, "average": 0.827933, "min": 0.272552}, "location": {"width": 86, "top": 1918, "height": 22, "left": 1131}, "words": " -FU/, Y"}, {"probability": {"variance": 0, "average": 0.993509, "min": 0.99282}, "location": {"width": 36, "top": 1934, "height": 25, "left": 669}, "words": "225"}, {"probability": {"variance": 0.036873, "average": 0.894945, "min": 0.510945}, "location": {"width": 64, "top": 1959, "height": 27, "left": 1122}, "words": "N=145"}], "language": 3}